ReGenesys is a wholly-owned affiliate of Athersys, a publicly held biotechnology company located in Cleveland, Ohio (NASDAQ: ATHX).
The company's major core business unit is a stem cell therapeutic opportunity, based on pluripotent stem cells isolated from bone marrow. The company has established master cell banks and successfully produced a cGMP cell product by FDA guidelines, MultiStem®. ReGenesys is establishing stem cell banks in Europe and is focusing on manufacturing to support clinical activities. ReGenesys is also actively performing basic research to serum-free media formulations and epigenetics.